C
Niagen Bioscience, Inc. NAGE
$6.01 -$0.27-4.30% NASDAQ
Recommendation
Prev Close
$6.28
Volume
648,221
Avg Vol (90D)
969,781
Market Cap
$502.96M
Dividend & Yield
--
52-Week Range
$5.25 - $14.69
P/E (TTM)
26.57
EPS (TTM)
$0.24
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
THE FOCUS DOCTRINE: 5 Assets Securing the 2026 Biological Choke Point
1/21/2026 - Globe Newswire
Niagen Bioscience (NAGE, $6.19) Stochastic Oscillator left the oversold zone on January 16, 2026
1/17/2026 - Tickeron - Stocks
A Look At Niagen Bioscience (NAGE) Valuation After New HSA And FSA Purchasing Option For Tru Niagen
1/16/2026 - Simply Wall St
Niagen Bioscience (NAGE, $6.31) Moving Average Convergence Divergence (MACD) Histogram turned negative on January 15, 2026
1/16/2026 - Tickeron - Stocks
Niagen Bioscience partners with Truemed for pre-tax health payments
1/15/2026 - TipRanks Financial Blog
Niagen Bioscience partners with Truemed for pre-tax health payments
1/15/2026 - The Fly
Niagen Bioscience Expands HSA/FSA Access for Tru Niagen, the Leading NAD+ Supplement in the U.S.*
1/15/2026 - Business Wire
Is Niagen Bioscience (NAGE) Using Investor Summits To Recast Its Healthy Aging Strategy Narrative?
1/15/2026 - Simply Wall St
Niagen Bioscience (NAGE, $6.52) entered Downtrend as Momentum indicator drops below 0 level on Jan 09, 2026
1/10/2026 - Tickeron - Stocks
Niagen Bioscience (NAGE, $6.57) entered Downtrend as Momentum indicator drops below 0 level on Jan 07, 2026
1/8/2026 - Tickeron - Stocks
Niagen Bioscience: Why Discipline Matters In A Crowded Supplement Market
1/5/2026 - SeekingAlpha
Niagen Bioscience, Inc. (NASDAQ:NAGE) Receives Consensus Rating of "Moderate Buy" from Brokerages
1/5/2026 - MarketBeat
Niagen Bioscience (NAGE, $6.25) entered Downtrend as Momentum indicator drops below 0 level on Jan 02, 2026
1/3/2026 - Tickeron - Stocks
Niagen Bioscience (NAGE, $6.36) Stochastic Oscillator left the oversold zone on December 31, 2025
1/1/2026 - Tickeron - Stocks
Precision Wealth Strategies LLC Makes New $1.53 Million Investment in Niagen Bioscience, Inc. $NAGE
12/26/2025 - MarketBeat
Roth MKM Reaffirms Their Buy Rating on Niagen Bioscience (NAGE)
12/24/2025 - TipRanks Financial Blog
Niagen Bioscience (NAGE) Secures Key Patents, Boosts Revenue Forecast
12/22/2025 - GuruFocus
Niagen Bioscience (NAGE) Secures Exclusive Ownership of Key Patent Portfolio
12/22/2025 - GuruFocus
Niagen Bioscience acquires core Nicotinamide Riboside patents
12/22/2025 - SeekingAlpha.com: All News
Niagen Bioscience acquires core Nicotinamide Riboside patents
12/22/2025 - Seeking Alpha - Healthcare
Niagen Bioscience Acquires Existing Core Nicotinamide Riboside (NR) Patent Portfolio from ...
12/22/2025 - GuruFocus
Niagen Bioscience acquires existing nicotinamide riboside patent portfolio
12/22/2025 - The Fly
Niagen Bioscience Acquires Existing Core Nicotinamide Riboside (NR) Patent Portfolio from Queens University Belfast
12/22/2025 - Business Wire
Niagen Bioscience (NAGE, $6.34) Stochastic Oscillator left the oversold zone on December 16, 2025
12/17/2025 - Tickeron - Stocks
Niagen Bioscience (NAGE, $6.63) Stochastic Oscillator left the oversold zone on December 11, 2025
12/12/2025 - Tickeron - Technical Analysis
Income Statement
Total Revenue (TTM)
$124.71M
EBITDA (TTM)
$20.08M
EBIT (TTM)
$19.30M
Net Income (TTM)
$20.43M
Balance Sheet
Total Assets (Q)
$98.14M
Total Debt (Q)
$3.06M
Total Liabilities (Q)
$27.46M
Book Value Per Share (Q)
$0.8843
Cash Flow
Cash from Operations (TTM)
$21.41M
Cash from Investing (TTM)
-$260.00K
Cash from Financing (TTM)
$10.74M
Net Change in Cash (TTM)
$31.89M
Filings
Filing Date
Tuesday, November 4, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 2 and 6 (est)
Price History
Loading...
Beta
1.64
7-Day Total Return
-7.54%
30-Day Total Return
-7.68%
60-Day Total Return
-20.92%
90-Day Total Return
-37.91%
Year to Date Total Return
-3.84%
1-Year Total Return
0.50%
2-Year Total Return
341.91%
3-Year Total Return
232.04%
5-Year Total Return
22.90%
52-week Low
Feb 24, 2025 - $5.25
52-week High
Jun 30, 2025 - $14.69
Valuation
Market Cap
$502.96M - Small Cap
Enterprise Value
$441.88M
Price/Sales (TTM)
4.36
Price/Book (Q)
7.10
Dividends and Shares
Shares Outstanding
86.62M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.niagenbioscience.com
Phone Number
310 388 6706
Address
10900 Wilshire Blvd
Los Angeles, CA 90024
Country
United States
Year Founded
1999
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical... more
NASDAQ 01/23/2026 4:00PM Eastern Quotes delayed